<code id='FCD0A03981'></code><style id='FCD0A03981'></style>
    • <acronym id='FCD0A03981'></acronym>
      <center id='FCD0A03981'><center id='FCD0A03981'><tfoot id='FCD0A03981'></tfoot></center><abbr id='FCD0A03981'><dir id='FCD0A03981'><tfoot id='FCD0A03981'></tfoot><noframes id='FCD0A03981'>

    • <optgroup id='FCD0A03981'><strike id='FCD0A03981'><sup id='FCD0A03981'></sup></strike><code id='FCD0A03981'></code></optgroup>
        1. <b id='FCD0A03981'><label id='FCD0A03981'><select id='FCD0A03981'><dt id='FCD0A03981'><span id='FCD0A03981'></span></dt></select></label></b><u id='FCD0A03981'></u>
          <i id='FCD0A03981'><strike id='FCD0A03981'><tt id='FCD0A03981'><pre id='FCD0A03981'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:9565
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          AstraZeneca chief proposes a novel edit to the drug pricing bill
          AstraZeneca chief proposes a novel edit to the drug pricing bill

          PascalSoriotofAstraZenecaSTATAmongthepharmaceuticalcompanies’manyobjectionstotheBidenadministration’

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

          ComedianandfilmmakerLaurenMillerRogenandherhusband,actorandcomedianSethRogen,speakaboutAlzheimer'sca